Prevalence and risk factors associated with Hepatitis B virus coinfection with HIV amon patients attending some selected hospitals in Kaduna metropolis
Keywords:Hepatitis B virus, Human immunodeficiency virus, Co-infection, Prevalence
300 blood samples were analyzed for the presence of Hepatitis B surface antigen (HBsAg), using smart checkTM HBsAg strip. 270 were HIV positive while 30 were HIV negative patients. Out of the 270 HIV positive patients 35 (13.0%) were HBsAg positive while out of the 30 HIV negative patients 1 (3.3%) was HBsAg positive. Prevalence was highest in age group 15-20 (25.0%) with zero prevalence in age group below 15 and above 51 in HIV positive patients, there is significant statistical association between age and the occurrence of HBV infection (P<0.05). Higher prevalence was recorded in males 16.2% than females 11.7%, there is no significant association between the occurrence of HBV and sex (P>0.05). Multiple sex partners have the highest prevalence (50.0%) and no sex partner have the lowest prevalence (5.3%).This reveals that patients that are HIV positive are at risk of contracting HBV infection.
Alter, M.J., 2006. Epidemiology of viral Hepatitis and HIV co infection. J. Hepatol. 44(1sppl), 56-59.
Fix, O.K., Locarmini, S.A., Peters, M.G., 2007. Virology and clinical management of Hepatitis B and HIV co-infection. Physician. Res. Network. 11.
Hamza, M., Samaila, A.A., Yakasai, A.M., Babashani, M., Borodo, M.M., Habib A.G., 2013. Prevalence of Hepatitis B and C virus infections among HIV infected patients in a tertiary hospital in North-western Nigeria, 10(2), 76-78.
Jawetz, Melnic, Adelberg’s, 2007. Medical Microbiology. In: Geo, F. B., Kacen, C.C., Janet, S.B. Stephen, A.M., 23rd International Edition, Mcgraw Hill Publisher, 550 – 569.
Mahoney, F.J., 1999. Update on diagnosis, management and prevention of Hepatitis B virus infection. Clin. Microbiol. Rev. 12, 351-366.
Pouti, M., Manno, D., Nasta, P., Carosi, G., 2008. Hepatitis B virus and HIV co-infection in low-income countries: Unmet Needs. Clin. Infect. Dis. 46, 367-369.
Rouet, F., Chaix, M.L., Inwoley, D., Anaky, M-F., Fissinou, P., Kpozehouen, A., Rouzioux, C., Blanche, S., Msellati, P., 2008. Chronic Hepatitis B virus (HBV) infections among West African human immunodeficiency Virus Type 1- infected children. Clin. Infect. Dis. 46, 361-366.
Sadoh, A.E., Sadoh, W.E., Iduoriyekemwen, N.J., 2011. HIV co-infection with Hepatitis B and C viruses among Nigerian children in an antiretroviral treatment programme. South. Afr. J. Child. Health. 5(suppl1), 7-10.
Sarka, J., Bandyopadhyay, B., Chakrabarty, R., Bhattacharya, N., Adhikan, S., Mondal, S., Mukherjee, A., Guha, S.K., 2013. HIV-HBV co-infection among individuals attending the ICTC of a tertiary care hospital in West Bengal India. Int. Sch. Res. Not. Virol.
Toukan, A., 1990. Strategy for the control of hepatitis B virus infection in the Middle East and North Africa. Vaccine. 8, S117-S121.
Uneke, C.J., Ogbu, O., Inyama, P.U., Anyanwu, G.I., Njoku, M.O., Idoko, J.H., 2005. Prevalence of Hepatitis B surface antigen among blood donors and Human Immunodeficiiency Virus infected patients in Jos, Nigeria. Memorias do instituto osswaldo cruz, 100(1), 13-16.
How to Cite
Copyright (c) 2020 A.M. Aliyu, Maryam Aliyu Yakasai, Afusat Bola Rufai
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.